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facilitating decaprenyl diphosphate biosynthesis in
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Abstract
Mycobacterium tuberculosis (Mtb) has a highly complex cell wall, which is required for both
bacterial survival and infection. Cell wall biosynthesis is dependent on decaprenyl diphosphate as
a glyco-carrier, which is hence an essential metabolite in this pathogen. Previous biochemical
studies indicated (E)-geranyl diphosphate (GPP) is required for the synthesis of decaprenyl
diphosphate. Here we demonstrate that Rv0989c encodes the “missing” GPP synthase,
representing the first such enzyme to be characterized from bacteria, and which presumably is
involved in decaprenyl diphosphate biosynthesis in Mtb. Our investigation also has revealed
previously unrecognized substrate plasticity of the farnesyl diphosphate synthases from Mtb,
resolving previous discrepancies between biochemical and genetic studies of cell wall
biosynthesis.
Keywords
Polyisoprenyl phosphates; Terpene Biosynthesis; Tuberculosis; Cell Wall biosynthesis; Genetic
fitness
1. Introduction
Mycobacterium tuberculosis (Mtb) is the main intracellular pathogen responsible for the
human disease Tuberculosis, which is particularly lethal in immune-deficient individuals.
Evolution of drug resistant strains has renewed this pathogen’s threat on the general
population, as these new strains are extremely pathogenic and untreatable by current
antibiotic regimens [1]. Furthermore, decades of research have failed to uncover the
pathogenic mechanism of Mtb, complicating drug design efforts. This elusive mechanism
likely involves a multifactorial attack, employing attack by a variety of virulence factors
over the course of the infection [2]. One set of these virulence factors involve the complex
mycobacterial cell wall and lipids, which have been linked to pathogenesis and survival of
the bacteria during infection [3].
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The mycobacterial cell wall is unique amongst bacteria. The cell wall consists of the
peptidoglycan, arabinogalactan, and mycolipid layers, as well as a capsule-like layer
separate from the core wall components [4] . Important in proper assembly of this complex
structure is the glyco-carrier polyprenyl phosphate (Pol-P) [5]. Such Pol-P molecules are
synthesized via the addition of isoprene units in the form of isopentenyl diphosphate (IPP) to
a variety of allylic isoprenyl diphosphate acceptors, which are found in varying lengths, as
well as various double bond isomers. Specifically, Mtb utilizes a 10 isoprene-unit
decaprenyl diphosphate to assemble its complex cell wall [6], which is formed by the
addition of seven IPP to (Z,E)-farnesyl diphosphate (FPP) by Rv2361c [7]. To synthesize
(Z,E)-FPP, one unit of IPP is added to (E)-geranyl diphosphate (GPP) by Rv1086 [7].
Previous work has indicated that this process is dependent on GPP as the allylic acceptor of
IPP, yet no GPP synthase has been characterized from Mtb [8] (Figure 1). In addition, while
Rv2361c is essential for bacterial survival [9], neither Rv1086 nor the remaining
uncharacterized prenyltransferases are similarly essential, complicating identification of the
prenyltransferases involved in decaprenyl diphosphate biosynthesis.
While studying the biosynthesis of the immune modulating diterpenoid, isotuberculosinol,
we uncovered four previously uncharacterized putative trans-prenyltransferases (Rv0989c,
Rv2173, Rv3383c, Rv0562) [10]. Of these prenyltransferases, only Rv0989c failed to
synthesize the (E,E,E)-geranylgeranyl diphosphate (GGPP) required for isotuberculosinol or
other diterpenoid biosynthesis. These initial assays were not set up to detect shorter chain
isoprenoids (i.e. FPP or GPP), leading to a lack of observed activity with Rv0989c. After
recognizing that a GPP synthase was expected, we altered our protocol to enable detection
of ten and fifteen carbon isoprenoids, and found that Rv0989c acts as a GPP synthase, that
seems to assist the production of FPP in Mtb. Furthermore, our analysis indicates that
Rv1086 is able to produce small amounts of (Z,E)-FPP from dimethylallyl diphosphate
(DMAPP), which may explain the non-essential nature of these prenyltransferases.
Accordingly, we describe here the first bacterial GPP synthase, and further clarify the roles
of the various isopentyl diphosphate synthases involved in production of the decaprenyl
diphosphate required for mycobacterial cell wall biosynthesis, thus resolving the apparent
contradictions between biochemical and genetic analysis of these enzymes.
2. Materials and methods
General
IPP, DMAPP, GPP, (E,E)-FPP, and GGPP were purchased from Isoprenoids, LC (Tampa,
FL). Corresponding dephosphorylated alcohol standards for gas chromatography (GC)
analysis were purchased from Sigma Aldrich (St. Louis, MO). Unless otherwise noted, all
other chemicals were purchased from Fisher Scientific (St. Louis, MO) and all molecular
biology reagents were purchased from Invitrogen (Carlsbad, CA). Sequence alignments
were carried out using the AlignX program from the Vector NTI software package
(Invitrogen), using standard parameters.
Cloning, expression, and purification
Rv0989c and Rv3398c were cloned from Mycobacterium tuberculosis CDC1551, while
Rv1086 was obtained as a synthetic construct, codon-optimized for expression in
Escherichia coli. These were cloned into pENTR/SD/D-TOPO prior to directional
recombination into an expression vector containing a 6xHis N-terminal fusion (pDEST17,
Gateway, Invitrogen). Proteins were expressed in E. coli strain C41 (Lucigen, Middleton,
WI), by growing the recombinant bacteria in NZY liquid media at 37 °C to an OD600 of 0.6,
transfer to 16 °C for 1 hr prior to induction with 0.5 mM IPTG, and subsequent 14–16 hr
fermentation. Cells were harvested via centrifugation and resuspended in Lysis Buffer (10
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mM Tris-Cl, 10% Glycerol, 1 mM Dithiothreitol) for sonication. The resulting lysates were
clarified via centrifugation (10 min x 10,000g). The recombinant proteins were then purified
over Ni-NTA Superflow resin (Novagen) following manufacturer protocols.
Prenyltransferase assay
The purified enzymes were characterized in Assay Buffer (50 mM sodium phosphate (pH
7.0), 10% glycerol, 5 mM MgCl2, 2 mM Dithiothreitol), with IPP and allylic isoprenyl
diphosphate substrate (i.e. DMAPP, GPP, or FPP), in a final volume of 1 mL at 37 °C.
Assays were stopped by the addition of 1 ml of Stopping Solution (9:1 Methanol: 3N
Hydrochloric acid), which also dephosphorylates the substrates and products, and 1 mL of
pentane was added immediately and mixed to allow for full partitioning of the isoprenoid
alcohols to the organic solvent layer. This was removed and dried under a stream of N2 at
room temperature prior to resuspension in 50 μL hexanes. Enzymatic products were
identified on a gas chromatograph (GC) with mass spectrometry (MS) detection using a
Varian 3900 GC with Saturn 2100T ion-trap MS (Varian Inc, Palo Alto, CA) with
comparison to authentic standards, and were quantified via an Agilent 6890 GC with flame
ionization detection (FID)(Agilent Technologies, Santa Clara, CA), using a previously
published method [11].
Characterization of Rv0989c
Rv0989c was determined to produce GPP, and then assays with this enzyme optimized for
protein concentration and incubation time to obtain initial linear reaction rates. It was
necessary to use ≥ 0.5 μM enzyme to achieve linearity, with incubation times of 2 minutes
then found to be optimal. Steady-state kinetic constants were determined by varying
concentrations of either substrate, i.e. 10–300 μM IPP or 5– 200 μM DMAPP, with the other
held constant at the highest relevant concentration, which initial analysis had determined
was saturating. Concentrations of both the internal standard (cembrene) and product were
determined by integration of peaks after separation and detection by GC-FID. The observed
data was fit to the Michaelis-Menten equation (KaleidaGraph 4.0, Synergy Software;
Reading, PA), resulting in R-values ≥ 0.97.
Coupled assays
Coupled assays were carried out by pre-incubating Rv0989c (5 μM) with DMAPP (100 μM)
and IPP (100 μM) for 5 min. prior to the addition of Rv1086 (1 μM) or Rv3398c (0.35 μM),
along with an additional 50 μM IPP, and the assay incubated for an additional 5 minutes
before stopping. Control assays with Rv1086 or Rv3398c, in the absence of Rv0989c, using
100 μM of GPP or DMAPP as the allylic substrate, were run for 5 minutes. These all were
analyzed by GC-MS, as described above, for production of the relevant isomers of FPP
using separate methods, allowing for distinct separation of the resulting dephosphorylated
farnesol (i.e. (E,E)-farnesol [12] or (Z,E)-farnesol [11]).
Characterization of Rv3398c and Rv1086
Rv3398c was kinetically characterized as described above for Rv0989c, using substrate
concentrations ranging from 2.5–200 μM. Time course studies with Rv1086 were performed
with 100 μM each of IPP and DMAPP. When Rv1086 was assayed alone, Triton X-100 was
added at 0.3 % (v/v) to the Assay Buffer to mimic previously reported conditions [8].
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Characterization of Rv0989c as a GPP synthase
Rv0989c was initially screened for GGPP synthesis based on its homology to other GGPP
synthases within the Mtb genome (Rv0562, Rv2173, Rv3383c) [10]. As Rv0989c failed to
synthesize GGPP from any allylic precursor (DMAPP, GPP, or FPP), it was then assessed
for activity as a GPP or FPP synthase, and found to produce GPP when incubated with
DMAPP and IPP (Figure 2). Although production of (E,E)-FPP was occasionally observed
in the presence of excess (>1 mM) substrate, this likely indicates non-physiologically
relevant reuptake of product for further elongation under these conditions. Steady-state
kinetic analysis of Rv0989c revealed unusual behavior. When varying DMAPP
concentration in the presence of saturating amounts of IPP, kcat appeared to be 0.7 min−1,
which is over 7.5-fold lower than that measured when varying IPP concentration in the
presence of saturating amounts of DMAPP, where kcat appeared to be 5.1 min−1. Yet the
pseudo-substrate binding constant KM suggests DMAPP is bound three-fold tighter than IPP
(58 versus 163 μM, respectively). This may indicate non-catalytically relevant binding of
two molecules of IPP at high concentrations, necessitating displacement by DMAPP that
decreases the observed catalytic rate.
Rv0989c facilitates production of (Z,E)-FPP by Rv1086 and (E,E)-FPP by Rv3398c
Decaprenyl diphosphate formation in Mtb proceeds through Rv1086, a (Z,E)-FPP synthase,
which has been reported to use exclusively GPP as its allylic isoprenyl diphosphate substrate
[8]. Similarly, Rv3398c, the Mtb (E,E)-FPP synthase, also has been reported to utilize GPP
exclusively [13]. To demonstrate that Rv0989c synthesizes the required product for further
elaboration into these important isoprenyl diphosphates, Rv0989c was assayed with each of
these FPP synthases. Coupled assays with Rv0989c and Rv1086 led to production of
significant amounts of (Z,E)-FPP (Figure 3), along with smaller amounts (<10%) of (E,E)-
FPP (data not shown). Surprisingly, a small amount of (Z,E)-FPP also was produced by
Rv1086 from IPP and DMAPP in the absence of Rv0989 (Figure 3). Nevertheless, time
course measurements indicate the coupled reaction proceeds at a faster rate and nets higher
yields of (Z,E)-FPP (Figure 4), supporting a role for GPP as the preferred substrate for this
enzyme. Coupled assays with Rv0989c and Rv3398c produce (E,E)-FPP (Figure 5).
However, again, when assayed only in the presence of DMAPP and IPP, Rv3398c is able to
produce (E,E)-FPP at measureable rates. Steady state kinetic analysis of Rv3398c
determined that kcat is 1.5 ± 0.1 min−1, KM for IPP is 2.6 ± 0.4 μM, while that for DMAPP is
20 ± 9 μM. Comparing to previous publications [13], this still suggests that GPP (KM = 10
μM) is the preferred allylic isoprenyl diphosphate substrate for Rv3398c.
4. Discussion
The mycobacterial cell wall has been extensively studied as it is exceptionally reinforced
and uniquely immunogenic [3]. Key to the assembly of this complex structure is the glyco-
carrier decaprenyl diphosphate [6]. Though clearly required for cell growth, development,
and viability [9], the biosynthetic pathways utilized in synthesis of decaprenyl diphosphate
have frustrated scientists in recent decades. Genetic and biochemical analysis of the
biosynthetic machinery has failed to completely characterize the pathway. While decaprenyl
diphosphate production is required for cell wall biosynthesis [14], genetic analysis indicates
that only the final step in the production of this important metabolite (that catalyzed by the
gene product of Rv2361c) is absolutely required for bacterial viability [9]. While this
decaprenyl diphosphate synthase will accept a range of allylic isoprenyl diphosphate
substrates [7], it has been reported that the production of its preferred (Z,E)-FPP primer for
elongation is completely dependent on the availability of GPP [8]. Previously, neither
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genetic nor biochemical analysis was able to identify the corresponding GPP synthase in
Mtb, which our results now demonstrate is encoded by Rv0989c.
To the best of our knowledge, Rv0989c is the first characterized bacterial GPP synthase.
While this does exhibit homology to other such trans-prenyltransferases, there are a number
of surprising substitutions observed in Rv0989c. In particular, while readily aligned with
other known GPP synthases (Figure 6), Rv0989c contains remarkable changes within two
otherwise well-conserved aspartate-rich motifs (designated as the first and second, FARM
and SARM, respectively). In Rv0989c, the second aspartate of the FARM and the first
aspartate of the SARM are replaced by arginine, and the final aspartate of the SARM is
replaced by an alanine, whereas the only other naturally found substitutions are asparagines.
Indeed, site-directed mutations in the first and second aspartate of the SARM of other trans-
prenyltransferases to alanine, specifically an (E,E)-FPP synthase from Saccharomyces
cerevisiae, have demonstrated a drastic loss of activity [15]. The significance of the
observed divergence in the FARM and SARM of Rv0989c is not readily apparent, but their
expected deleterious effects may have been a contributing factor to the previous difficulty in
identification of a GPP synthase in the Mtb genome.
We have determined Rv0989c is able to provide the GPP precursor required for efficient
production of both double bond isomers of FPP in Mtb, as demonstrated by coupled assays
with the relevant FPP synthases (encoded by Rv1086 and Rv3398c). However, our
enzymatic analysis also revealed that both of these are able to react with the shorter,
universal allylic isoprenyl diphosphate substrate DMAPP. This clarifies the contradictory
biochemical and genetic evidence regarding the decaprenyl diphosphate biosynthetic
pathway in Mtb [8,9,13]. In particular, knockout analysis of these prenyltransferases in Mtb
have demonstrated that they are not required for viability, indicating that cell wall
biosynthesis was able to proceed in their absence, despite biochemical evidence indicating
that decaprenyl diphosphate production depends on their activity/products. Nevertheless,
these findings further highlight the need for development and study of functional, non-lethal
knockouts in Mtb cell wall biosynthetic machinery, as many questions have yet to be
answered regarding bacterial tolerance and flexibility for substitutions in this process. This
important component of Mtb viability and pathogenesis needs to be completely understood
before the puzzle that is the Mtb pathogenic mechanism will be solved.
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Decaprenyl diphosphate biosynthesis in Mycobacterium tuberculosis. The roles of Rv1086
and Rv2361c have been demonstrated, yet biochemical analysis indicated they are
dependent on a previously uncharacterized GPP synthase, which is demonstrated here to be
encoded by Rv0989.
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Figure 2. Confirmation of Rv0989c activity
Comparison of dephosphorylated Rv0989c product to GPP-derived GOH. (A) GC-FID
chromatograms. (B) GC-MS mass spectra.
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Figure 3. Production of (Z,E)-FPP-derived FOH by Rv0989c/Rv1086
GC-MS analysis of product profiles from Rv1086 assayed in the presence of authentic GPP,
GPP synthesized by Rv0989c, or DMAPP. (A) Total ion chromatograms. (B) mass spectra.
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Figure 4. Time-dependent production of (Z,E)-FPP by Rv1086
(Z,E)-FPP-derived FOH synthesis by Rv1086 assayed in the presence of 100 uM IPP and
100 uM DMAPP (squares) or 100 uM IPP, 100 uM DMAPP, and Rv0989c (circles). Smooth
fit lines were applied.
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Figure 5. Production of (E,E)-FPP-derived FOH by Rv0989c/Rv3398c
GC-MS analysis of product profiles from Rv3398 assayed in the presence of authentic GPP
and GPP synthesized by Rv0989c. (A) Total ion chromatograms. (B) mass spectra.
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Figure 6. Alignment of Rv0989c with confirmed GPP synthases
Alignment of the Rv0989c gene product with that of the GPP synthases from Ips pini
(IpGPS) [16], Aphis gossypii (AgGPS) [17], Arabidopsis thaliana (AtGPS) [18], and Citrus
sinensus (CsGPS) [19]. The first- and second aspartate-rich motifs (FARM and SARM,
respectively), are underlined, with the non-canonical substitution of arginine or alanine
residues for otherwise conserved active site aspartate residues in Rv0989c indicated by *
and # above the relevant position, respectively.
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